Related Experiment Video
Updated: Jul 12, 2025

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody
Published on: May 16, 2020
The foreign body response: emerging cell types and considerations for targeted therapeutics
Brenda Yang1, Natalie Rutkowski1, Jennifer Elisseeff1,2
1Translational Tissue Engineering Center, Wilmer Eye Institute and Department of Biomedical Engineering, Johns Hopkins University, Baltimore, MD, USA. jhe@jhu.edu.
The foreign body response (FBR) to biomaterials involves complex immune cells beyond classical mediators. Understanding T cells, stromal-immune interactions, and senescent cells can improve implant integration and healing.
Area of Science:
- Biomaterials Science
- Immunology
- Tissue Engineering
Background:
- The foreign body response (FBR) is a significant challenge in biomaterials, causing chronic immune reactions and implant isolation.
- Current understanding of FBR mediators is incomplete, necessitating exploration of diverse cellular players.
- Modulating immune responses to biomaterials is key for enhancing tissue repair and integration.
Purpose of the Study:
- To review the emerging roles of T cells, stromal-immune cell interactions, and senescent cells in the FBR.
- To highlight the need for deeper investigation into these cell types for therapeutic target identification.
- To discuss factors influencing FBR in humans, such as models, aging, microbiota, and sex differences.
Main Methods:
- Literature review focusing on recent studies of cellular mechanisms in FBR.
- Analysis of the role of specific cell types (T cells, senescent cells) and cell-cell interactions.
- Discussion of translational considerations for human FBR.
Main Results:
- Emerging evidence points to T cells, stromal-immune interactions, and senescent cells as critical, yet underappreciated, contributors to the FBR.
- These cellular components significantly influence the host's reaction to synthetic biomaterials.
- Understanding these heterogeneous responses is crucial for designing next-generation immunomodulatory materials.
Conclusions:
- A comprehensive understanding of the heterogeneous host cell response in FBR is essential for improving biomaterial performance.
- Targeting novel cellular mediators can lead to enhanced implant integration and reduced fibrous encapsulation.
- Future research should focus on these cellular players and human-specific factors to advance biomaterial design.
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Tumor Immunotherapy
Cytotoxic T Cells-mediated Immune Response
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Humoral Immune Responses
Cell-mediated Immune Responses
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...

